• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Oregon Issues US’s First Psilocybin License

Microdose NewsDesk by Microdose NewsDesk
March 24, 2023
in Law & Politics
Reading Time: 3 mins read
A A

Oregon Health Authority (OHA) has issued the state’s first psilocybin license as part of the nation’s first regulatory framework for psilocybin services. The manufacturer license was issued to Satori Farms.

The Oregon Psilocybin Services (OPS) is starting to award licenses to psilocybin facilitators, manufacturers, service centers, and laboratories. It began accepting applications on January 2, 2023 and expects to issue additional licenses in the coming months. See below for the full press release.

For more on Oregon’s psilocybin programs and roll-out, check Oregon’s Psilocybin Healing Centers: What You Need to Know and Psilocybin Therapy is Now Legal in Oregon — But There’s a Catch

 

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

Oregon Psilocybin Services issues state’s first licenses

 

PORTLAND, Ore. – Oregon Health Authority (OHA) has issued the state’s first psilocybin license as part of the nation’s first regulatory framework for psilocybin services. The manufacturer license was issued to a woman-owned business, Satori Farms PDX LLC, owned by Tori Armbrust. As the nation celebrates Women’s History Month, this woman-owned business will bring communities one step closer towards accessing psilocybin services in Oregon.

“We congratulate Tori Armbrust of Satori Farms PDX LLC for being issued the first psilocybin license in Oregon’s history and for representing women leading the way for the emerging psilocybin ecosystem,” says Oregon Psilocybin Services Section Manager Angie Allbee. “We are committed to fostering an inclusive partnership with our regulated community to ensure safe, effective and equitable psilocybin services throughout the state.”

Order Lasix Pills

The role of Oregon Psilocybin Services (OPS) is to license psilocybin facilitators, manufacturers, service centers and laboratories, while ensuring that those licensees and their workers comply with Oregon law. OPS began accepting applications for the four license types on January 2, 2023. OPS expects to issue additional licenses to laboratories, service centers and facilitators in the coming months.

Anyone interested in accessing psilocybin services can find service centers and facilitators once they are licensed on the OPS Licensee Directory website. The directory will contain licensee names and contact details for all licensees that have requested to have their information published. This may also provide opportunities for licensed psilocybin businesses to connect.

Oregon Psilocybin Services (OPS) has also begun publishing a Weekly Report on Applications for Licenses and Worker Permits. The new weekly report includes information about total number of applications received by type and status. OPS will update the report on a weekly basis.

OPS encourages the public to visit the OPS website for more information and to sign up for updates on the section’s work.

For the latest updates, subscribe to the Oregon Psilocybin Services distribution list at: oregon.gov/psilocybin

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Decriminalizationpsilocybin
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
Ketamine Patients Suffer From Clinic Closings, Telehealth Rules

Ketamine Patients Suffer From Clinic Closings, Telehealth Rules

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.